Three months of rifapentine and isoniazid for latent tuberculosis infection.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Chaisson RE, TB Trials Consortium PREVENT TB Study Team
N Engl J Med. 2011 365 (23): 2155-66

PMID: 22150035 · DOI:10.1056/NEJMoa1104875

MeSH Terms (17)

Adult Antitubercular Agents Directly Observed Therapy Drug Administration Schedule Drug Therapy, Combination Follow-Up Studies Humans Intention to Treat Analysis Isoniazid Male Middle Aged Prospective Studies Rifampin Risk Factors Self Administration Tuberculosis Virus Latency

Connections (1)

This publication is referenced by other Labnodes entities: